Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Real-World Safety and Efficacy of Consolidation Durvalumab After Chemoradiation Therapy for Stage III Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis

Published:2021-12 Issue: Volume: Page:
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Wang Yu,Zhang Tao,Huang Yilin,Li Wei,Zhao Jingjing,Yang Yin,Li Canjun,Wang Luhua,Bi Nan

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference53 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Locally advanced non-small cell lung cancer: The past, present, and future;Govindan;J Thorac Oncol,2008

3. Non-small-cell lung cancer;Gridelli;Nat Rev Dis Primers,2015

4. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

5. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105;Yamamoto;J Clin Oncol,2010

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer;Frontiers in Immunology;2024-08-01

2. Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR);Radiotherapy and Oncology;2024-07

3. Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors;Cancer Communications;2024-06-05

4. Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy;Journal of the National Cancer Center;2024-06

5. Longitudinal circulating tumour DNA dynamics predict failure patterns and efficacy of consolidation immunotherapy after chemoradiotherapy in locally advanced non‐small‐cell lung cancer;Clinical and Translational Medicine;2024-03